ICON Price to Sales Ratio 2010-2023 | ICLR
Historical PS ratio values for ICON (ICLR) over the last 10 years. The current P/S ratio for ICON as of May 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ICON P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-01 | 301.61 | 3.07 | |
| 2023-12-31 | 283.07 | $98.15 | 2.88 |
| 2023-09-30 | 246.25 | $96.96 | 2.54 |
| 2023-06-30 | 250.20 | $95.74 | 2.61 |
| 2023-03-31 | 213.59 | $94.80 | 2.25 |
| 2022-12-31 | 194.25 | $93.87 | 2.07 |
| 2022-09-30 | 183.78 | $97.77 | 1.88 |
| 2022-06-30 | 216.70 | $97.33 | 2.23 |
| 2022-03-31 | 243.22 | $90.14 | 2.70 |
| 2021-12-31 | 309.70 | $83.22 | 3.72 |
| 2021-09-30 | 262.02 | $69.79 | 3.75 |
| 2021-06-30 | 206.71 | $59.88 | 3.45 |
| 2021-03-31 | 196.37 | $55.25 | 3.55 |
| 2020-12-31 | 194.98 | $52.42 | 3.72 |
| 2020-09-30 | 191.09 | $51.51 | 3.71 |
| 2020-06-30 | 168.46 | $51.34 | 3.28 |
| 2020-03-31 | 136.00 | $52.41 | 2.60 |
| 2019-12-31 | 172.23 | $51.61 | 3.34 |
| 2019-09-30 | 147.34 | $50.65 | 2.91 |
| 2019-06-30 | 153.97 | $49.56 | 3.11 |
| 2019-03-31 | 136.58 | $48.49 | 2.82 |
| 2018-12-31 | 129.21 | $47.30 | 2.73 |
| 2018-09-30 | 153.75 | $43.20 | 3.56 |
| 2018-06-30 | 132.53 | $39.31 | 3.37 |
| 2018-03-31 | 118.14 | $35.52 | 3.33 |
| 2017-12-31 | 112.15 | $32.04 | 3.50 |
| 2017-09-30 | 113.88 | $31.46 | 3.62 |
| 2017-06-30 | 97.79 | $30.84 | 3.17 |
| 2017-03-31 | 79.72 | $30.19 | 2.64 |
| 2016-12-31 | 75.20 | $29.51 | 2.55 |
| 2016-09-30 | 77.37 | $28.49 | 2.72 |
| 2016-06-30 | 70.01 | $27.61 | 2.54 |
| 2016-03-31 | 75.10 | $26.64 | 2.82 |
| 2015-12-31 | 77.70 | $25.79 | 3.01 |
| 2015-09-30 | 70.97 | $25.40 | 2.79 |
| 2015-06-30 | 67.30 | $24.98 | 2.69 |
| 2015-03-31 | 70.53 | $24.62 | 2.86 |
| 2014-12-31 | 50.99 | $23.88 | 2.14 |
| 2014-09-30 | 57.23 | $23.07 | 2.48 |
| 2014-06-30 | 47.11 | $22.40 | 2.10 |
| 2014-03-31 | 47.55 | $21.86 | 2.17 |
| 2013-12-31 | 40.42 | $23.17 | 1.74 |
| 2013-09-30 | 40.93 | $22.61 | 1.81 |
| 2013-06-30 | 35.43 | $21.90 | 1.62 |
| 2013-03-31 | 32.29 | $21.07 | 1.53 |
| 2012-12-31 | 27.76 | $19.89 | 1.40 |
| 2012-09-30 | 24.37 | $18.94 | 1.29 |
| 2012-06-30 | 22.53 | $18.16 | 1.24 |
| 2012-03-31 | 21.22 | $17.40 | 1.22 |
| 2011-12-31 | 17.11 | $16.76 | 1.02 |
| 2011-09-30 | 16.08 | $16.58 | 0.97 |
| 2011-06-30 | 23.56 | $16.35 | 1.44 |
| 2011-03-31 | 21.59 | $16.21 | 1.33 |
| 2010-12-31 | 21.90 | $16.34 | 1.34 |
| 2010-09-30 | 21.62 | $16.30 | 1.33 |
| 2010-06-30 | 28.89 | $16.27 | 1.78 |
| 2010-03-31 | 26.41 | $16.28 | 1.62 |
| 2009-12-31 | 21.73 | $14.82 | 1.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.574B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.851B | 15.41 |
| Cencora (COR) | United States | $47.686B | 19.03 |
| DiDi Global (DIDIY) | China | $24.011B | 0.00 |
| Avantor (AVTR) | United States | $16.459B | 24.23 |
| Viatris (VTRS) | United States | $13.776B | 3.96 |
| CochLear (CHEOY) | Australia | $13.705B | 0.00 |
| Revvity (RVTY) | United States | $12.658B | 22.18 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.086B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.032B | 39.59 |
| Charles River Laboratories (CRL) | United States | $11.796B | 21.50 |
| Natera (NTRA) | United States | $11.354B | 0.00 |
| Solventum (SOLV) | United States | $11.215B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.770B | 50.58 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 19.65 |
| Organon (OGN) | United States | $4.786B | 4.61 |
| Doximity (DOCS) | United States | $4.531B | 33.74 |
| PACS (PACS) | United States | $3.749B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.171B | 29.35 |
| Sotera Health (SHC) | United States | $3.170B | 15.56 |
| Progyny (PGNY) | United States | $3.081B | 51.71 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.687B | 29.70 |
| Premier (PINC) | United States | $2.502B | 9.16 |
| AMN Healthcare Services Inc (AMN) | United States | $2.273B | 7.35 |
| Agilon Health (AGL) | United States | $2.261B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.162B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.830B | 0.00 |
| Agiliti (AGTI) | United States | $1.381B | 22.56 |
| Establishment Labs Holdings (ESTA) | $1.373B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.317B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.982B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.745B | 7.71 |
| Embecta (EMBC) | United States | $0.583B | 3.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Enhabit (EHAB) | United States | $0.506B | 45.86 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| LifeMD (LFMD) | United States | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.445B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.437B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| CareDx (CDNA) | United States | $0.402B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.379B | 0.00 |
| DocGo (DCGO) | United States | $0.352B | 56.33 |
| ModivCare (MODV) | United States | $0.333B | 4.42 |
| Ascend Wellness Holdings (AAWH) | United States | $0.304B | 0.00 |
| Sharecare (SHCR) | United States | $0.259B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.33 |
| Oncology Institute (TOI) | United States | $0.079B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |